FRANKFURT (Reuters) - Sanofi's new CEO will continue its strategy of diversifying beyond new drug development, possibly through acquisitions, the French drugmaker's interim chief executive said. "We want to have businesses like consumer healthcare, veterinary medicine and vaccines that are less strongly driven by innovation but grow continuously and are more stable," German daily Handelsblatt quoted Serge Weinberg as saying in an interview published on Wednesday. ...
via Health News Headlines - Yahoo News http://ift.tt/1qtIZhX
No comments:
Post a Comment